Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)
Clinical trial NCT02227862 · COMPLETED
Trial details
- NCT number
- NCT02227862
- Sponsor
- Mylan Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-07-01
- Enrollment
- 558
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.